The shares of Exelixis, Inc. (NASDAQ:EXEL) has been pegged with a rating of Neutral by Goldman in its latest research note that was published on September 17th, 2018. The research company has also assigned a $22 price target. Goldman wasn’t the only research firm that published a report of Exelixis, Inc., with other equities research analysts also giving their opinion on the stock. Morgan Stanley advised investors in its research note published on September 10th, 2018, to Underweight the EXEL stock while also putting a $19 price target. The stock had earned Buy rating from Needham when it published its report on May 11th, 2018. That day the Needham set price target on the stock to $30. The stock was given Outperform rating by RBC Capital Mkts in its report released on October 17th, 2017, the day when the price target on the stock was placed at $39. Needham was of a view that EXEL is Buy in its latest report on October 17th, 2017 while giving it a price target of $33. SunTrust thinks that EXEL is worth Buy rating. This was contained in the firm’s report on October 16th, 2017 in which the stock’s price target was also moved to $35.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 2 believe it has the potential for further growth, thus rating it as Hold while 3 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $29.11. The price of the stock the last time has raised by 58.49% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 39.95.
The shares of the company added by 0.24% during the trading session on Friday, reaching a low of $20.73 while ending the day at $21.27. During the trading session, a total of 4.51 million shares were traded which represents a -6.59% decline from the average session volume which is 4.23M shares. EXEL had ended its last session trading at 21.22. Exelixis, Inc. currently has a market cap of $6.34B, while its P/E ratio stands at 18.06, while its P/E earnings growth sits at 8.53, with a beta of 2.27. Exelixis, Inc. debt-to-equity ratio currently stands at 0.00, while its quick ratio hovers at 8.50. EXEL 52-week low price stands at $13.42 while its 52-week high price is $30.24.
The company in its last quarterly report recorded $0.41 earnings per share which is above the $0.19 predicted by most analysts. The Exelixis, Inc. generated $225.40 million in revenue during the last quarter, which is slightly higher than the $172.59 million predicted by analysts. In the second quarter last year, the firm recorded $0.28 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 31.71%. Exelixis, Inc. has the potential to record 1.18 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Telsey Advisory Group published a research note on January 11th, 2019 where it informed investors and clients that Kohl’s Corporation (NYSE:KSS) is now rated as Outperform. Their price target on the stock stands at $80. Morgan Stanley also rated KSS as Initiated on September 10th, 2018, with its price target of $56 suggesting that KSS could surge by 12.09% from its current share price. Even though the stock has been trading at $66.54/share, analysts expect it to surge higher by -2.52% to reach $73.78/share. It started the day trading at $66.36 and traded between $64.55 and $64.86 throughout the trading session.
A look at its technical shows that KSS’s 50-day SMA is 66.17 while its 200-day SMA stands at 71.16. The stock has a high of $83.28 for the year while the low is $57.89. The company’s P/E ratio currently sits at 12.57, while the P/B ratio is 1.95. The company’s average trading volume currently stands at 3.92M shares, which means that the short-interest ratio is just 5.95 days. Over the past seven days, the company moved, with its shift of -2.74%. Looking further, the stock has dropped -19.17% over the past 90 days while it lost -12.85% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more KSS shares, increasing its portfolio by +0.29% during the last quarter. This move now sees The Vanguard Group Inc purchasing 52,315 shares in the last quarter, thus it now holds 18,395,694 shares of KSS, with a total valuation of $1,220,370,340. BlackRock Fund Advisors meanwhile bought more KSS shares in the recently filed quarter, changing its stake to $864,450,734 worth of shares. SSgA Funds Management Inc followed the path by increasing its KSS portfolio by +4.91% in the quarter. This means that SSgA Funds Management Inc bought 394,270 shares in the last quarter and now controls 8,421,761 shares of the KSS stock, with the valuation hitting $558,699,625.
Similarly, AQR Capital Management LLC increased its Kohl’s Corporation shares by +18.05% during the recently filed quarter. After buying 1,162,802 shares in the last quarter, the firm now controls 7,606,249 shares of Kohl’s Corporation which are valued at $504,598,559. In the same vein, LSV Asset Management decreased its Kohl’s Corporation shares by during the most recent reported quarter. The firm sold -178,622 shares during the quarter which decreased its stakes to 6,375,624 shares and is now valued at $422,958,896. Following these latest developments, around 0.70% of Kohl’s Corporation stocks are owned by institutional investors and hedge funds.